Creatinine

DB11846InvestigationalSmall molecule

Creatinine has been used in trials studying the treatment of Amyotrophic Lateral Sclerosis.

Chemical structure of Creatinine
Formula / weight
C4H7N3O · 113.1179 g/mol (avg)
Code names
NSC-13123

Resolves to

Compound
UNIIAYI8EX34EUCAS60-27-5ChEMBLCHEMBL65567ChEBI16737PubChem588KEGGC00791
Clinical / RWD
RxNorm2913
Structure
InChIKeyDDRJAANPRJIHGJ-UHFFFAOYSA-NSMILESCN1CC(=O)NC1=N

What you can answer from here — as of August 30, 2026

7Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Creatinine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In